针治疗通过MAPK酸化介导的神经炎症调节减轻纤维肌痛中心敏感性
Kezhi Liu1, Yuye Lin1, Tianyu Rao1
1College of acupuncture and moxibustion and Massage, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, Fujian Province, China.
Journal of orthopaedic surgery and research
|July 8, 2025
概括
针治疗 (ACP) 通过向中央敏感和MAPK信号通路,有效地减少纤维肌痛综合征 (FMS) 的疼痛和炎症. 这些发现支持ACP作为FMS管理的有针对性的干预.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 纤维肌痛综合征 (FMS) 是一种慢性疾病,原因不明,治疗方法有限.
- 中央敏感性是FMS病理生理学的关键因素.
- 针治疗 (ACP) 对FMS症状缓解有希望,但其机制尚不清楚.
研究的目的:
- 调查ACP如何影响FMS的老鼠模型中的中央敏感性和炎症.
- 阐明在FMS中ACP的治疗作用背后的分子机制.
主要方法:
- 开发了一个FMS老鼠模型来测试ACP的疗效.
- 使用行为测试评估疼痛和情绪困扰.
- 分析了MAPK通路活性,质细胞激活和炎症性细胞因子 (TNF-ɑ,IL-6),使用西斑和免疫光.
主要成果:
- 在FMS大鼠中,ACP显著降低了疼痛敏感性和改善了肌肉功能.
- ACP抑制了MAPK信号传递 (p38 MAPK,JNK MAPK),抑制了质激活,并降低了促炎性细胞因子水平.
- 治疗效果与翻译后的修改有关,而不是蛋白质合成/降解.
结论:
- 通过调节MAPK信号传递,中心敏感化和炎症,ACP提供多式FMS治疗.
- 经过精确的翻译后调节,ACP的效果得到了调节.
- 作为一个有针对性的FMS干预措施,ACP显示出潜力,支持其临床使用.
更多相关视频
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
2.1K
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
346
相关概念视频
Analgesia and Pain Management
816
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
816
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
